| Scientific Name |
Direct Acting Antivirals (DAAs)
|
|---|---|
| Brand Name |
Direct Acting Antivirals (DAAs)
|
| Risk |
Risk of hepatitis B reactivation.
|
| Safety Communication for Healthcare Professionals |
|